Fresenius Kabi AG
Fresenius Kabi is a multinational company specialising in drugs and technologies for infusion, transfusion and clinical nutrition, used to treat critically ill or chronically ill patients. In 2018, the company reported sales of more than EUR 6.5 billion. Fresenius Kabi AG is a wholly owned subsidiary of Fresenius SE & Co. KGaA healthcare group.
The customer’s requirement was to convert an existing warehouse part into a new production facility.
Planex was selected from among several candidates for its expertise in the pharmaceutical sector and its ability to manage a complex integrated design process as the sole overall coordinator.
The customer was given the executive project and the specialised technical report complete with all indications for the realisation of an efficient and high-performance production plant.